Article Information
History
- April 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Leah V. Dodds1,2,†,
- Alex P Sanchez-Covarrubias1,3,4,†,
- Ramlogan Sowamber1,3,†,
- Anca Milea5,
- Andre Pinto7,
- Yuguang Ban3,8,
- Matthew Schlumbrecht1,3,
- Patricia A Shaw5 and
- Sophia HL George1,3,*,9
- 1Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Miami Miller School of Medicine, Miami, FL, USA
- 2Medical Scientist Training Program, Prevention Sciences Graduate Program, University of Miami Miller School of Medicine, Miami, FL, USA
- 3Sylvester Comprehensive Cancer Center
- 4Cancer Biology Graduate Program, University of Miami Miller School of Medicine, Miami, FL, USA
- 5Princess Margaret Cancer Center, University Health Network, Ontario, Canada
- 6Department of Medicine, Internal Medicine Residency Program, University of Miami Miller School of Medicine, Miami, FL, USA
- 7Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA
- 8Department of Epidemiology and Population Health Sciences, Division of Biostatistics and Bioinformatics, University of Miami Miller School of Medicine, Miami, FL, USA
- ↵*Correspondence:
Dr. Sophia HL George, sophia.george{at}med.miami.edu
↵† Authors contributed equally
Posted April 23, 2023.
Hormone Receptor Expression and Disease Prognosis in High-Grade Serous Ovarian Cancer
